Drug details

Daytrana (methylphenidate transdermal)

type of

Daytrana (methylphenidate) is a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD).

This drug may have the following side effects:
  • hives,
  • difficulty breathing,
  • swelling of your face, lips, tongue, or throat,
  • lightheadedness,
  • chest pain,
  • numbness,
  • seizures,
  • hostility,
  • aggression,
  • hallucinations,
  • paranoia,
  • pain,
  • cold feeling,
  • changes in your vision,
  • new behavior problems,
  • unexplained wounds, and
  • skin color changes (pale, red, or blue appearance) in your fingers or toes
The following drugs are related to Daytrana, either as a replacement or used together:
  • Adzenys XR-ODT (amphetamine extended-release orally disintegrating tablets)
  • Dyanavel XR (amphetamine extended-release oral suspension)
  • Azstarys (serdexmethylphenidate and dexmethylphenidate capsules)
  • Kapvay (clonidine hydrochloride extended-release tablets)
  • Cotempla XR ODT (methylphenidate extended-release orally disintegrating tablets)
  • Xelstrym (dextroamphetamine)
  • ProCentra (dextroamphetamine sulfate oral solution)
  • Vayarin (lipirinen™ capsules)
  • Qelbree (viloxazine extended-release capsules)